Streetbeat News

Earnings

APYX

Apyx Medical's Q3 earnings per share (EPS) of $(0.13) missed the analyst consensus estimate of $(0.11) by 18.18%. The company's quarterly sales of $11.98 million also fell short of the analyst consensus estimate of $15.37 million by 22.08%. However, both EPS and sales showed an increase compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:04 pm

RCI

Rogers Communications (NYSE:RCI) reported Q3 earnings of $0.95 per share, beating the analyst consensus estimate of $0.79 by 19.87%. This is a 47.97% increase from the same period last year. The company also reported quarterly sales of $3.80 billion, beating the analyst consensus estimate of $3.74 billion by 1.49%. This is a 32.26% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:04 pm

XTNT

Xtant Medical Hldgs (AMEX:XTNT) reported Q3 earnings of $0.07 per share, a 333.33% increase YoY. The company's quarterly sales were $25.02 million, beating the analyst consensus estimate of $18.90 million by 32.38% and marking a 73.00% increase YoY.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:04 pm

BNRE

Brookfield Reinsurance (NYSE:BNRE) reported a 50% decrease in Q3 earnings per share YoY, from $0.14 to $0.07. Sales also decreased by 28.32% YoY, from $2.02 billion to $1.45 billion.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:03 pm

DBD

Diebold Nixdorf reported Q3 sales of $943.40 million, missing the analyst consensus estimate of $956.60 million by 1.38 percent. However, this is a 16.41 percent increase over sales of $810.40 million the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:03 pm

IRWD

Ironwood Pharmaceuticals reported Q3 adjusted earnings of $0.12 per share, missing the analyst consensus estimate of $0.16 by 25%. This is a 57.14% decrease from the same period last year. However, the company's quarterly sales of $113.74 million beat the analyst consensus estimate of $112.89 million by 0.75%, a 4.70% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:03 pm

DDS

Dillard's reported Q3 earnings of $9.30 per share, beating the analyst consensus estimate of $6.70 by 38.81%. However, this is a 15.15% decrease from the same period last year. The company's quarterly sales of $1.48 billion missed the analyst consensus estimate of $1.51 billion by 2.23%, marking a 4.38% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:02 pm

NOMD

Nomad Foods has increased its FY23 adjusted EPS guidance to €1.57-€1.60 from €1.54-€1.57. The company also reiterated its mid-single-digit organic revenue growth and adjusted cash flow conversion in the range of 90%-95%.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:02 pm

SHCR

Sharecare (NASDAQ:SHCR) reported Q3 adjusted earnings of $0.00 per share, beating the analyst consensus estimate of $(0.07) by 101.43%. However, the company's quarterly sales of $113.30 million missed the analyst consensus estimate of $113.63 million by 0.29%. This represents a 1.15% decrease over sales of $114.62 million from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:02 pm

NOMD

Nomad Foods reported Q3 adjusted earnings of $0.46 per share, beating the analyst consensus estimate of $0.41 by 12.2%. However, this is a 11.54% decrease from the same period last year. The company also reported quarterly sales of $831.58 million, beating the analyst consensus estimate of $802.26 million by 3.65%, and marking an 8.59% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:01 pm